COVID-19 Has Crystallized the Need for Effective Diagnostics at the Point-of-Need
COVID-19 Has Crystallized the Need for Effective Diagnostics at the Point-of-Need
COVID-19 Has Crystallized the Need for Effective Diagnostics at the Point-of-Need
COVID-19 Has Crystallized the Need for Effective Diagnostics at the Point-of-Need
COVID-19 Has Crystallized the Need for Effective Diagnostics at the Point-of-Need
Q-SENS - Enabling Fast, Multi-Biomarker Testing at Home and Point of Care
The Q-SENS Platform
The Q-SENS Platform by Proactive Diagnostics is a cutting-edge biosensing technology designed to deliver rapid, precise, and accessible diagnostic testing at the point of need. This platform offers central laboratory levels of sensitivity and specificity, providing results within 5 to 10 minutes. It utilizes minimally invasive sample collection, requiring only 10 microliters of fluid, facilitating simple self-testing. Q-SENS supports high multiplexing, enabling the simultaneous detection of up to 32 biomarkers in a single run, and is both cost-effective and quantitative, monitoring the kinetics rather than just the end-point test result.
The technology has demonstrated exceptional performance across over 50 different assays, making it applicable to a wide range of health conditions, including cardiovascular disease, infectious diseases, oncology, and both chronic and acute inflammatory markers. Additionally, it has potential uses in veterinary medicine, food safety, and dietary fields.
By integrating Q-SENS into various diagnostic applications, Proactive Diagnostics aims to revolutionize point-of-care testing, making it more efficient, affordable, and accessible to individuals and healthcare providers alike.
Our platform technology enables the simultaneous detection of proteins, nucleic acids, and small molecules, opening up a broad spectrum of applications and possibilities. With Q-SENS, we strive to deliver accessible, straightforward testing across diverse, innovative use cases.
Q-SENS has demonstrated outstanding performance in over 50 different assays, proving its versatility across health conditions such as cardiovascular disease, infectious disease, oncology, and both chronic and acute inflammation. Its applications extend to veterinary diagnostics, food safety testing, and dietary analysis, showcasing its adaptability across various fields.
We envision Q-SENS as the preferred platform for point-of-need biomarker measurement, delivering value wherever rapid, reliable testing is essential.
A Powerful Platform for Diverse Applications
Q-SENS is designed to meet the needs of a wide array of applications by providing rapid, precise biomarker detection. Its ability to simultaneously measure proteins, nucleic acids, and small molecules makes it a versatile tool across numerous fields. In healthcare, Q-SENS supports critical areas like cardiovascular health, infectious disease management, oncology, and inflammation monitoring, delivering high-sensitivity results that aid in early detection and informed decision-making.
Beyond human health, Q-SENS adapts seamlessly to veterinary medicine, food safety, and nutritional testing, where quick and accurate diagnostics can be transformative. By offering reliable, point-of-need testing with minimal sample requirements, Q-SENS is empowering professionals across industries to respond quickly and effectively to diagnostic challenges.
Q-SENS Test Flow
